Acquired Hypofibrinogenemia Before Asparaginase Exposure During Induction Therapy for Pediatric Acute Lymphoblastic Leukemia: A Report of 2 Cases and Review of the Literature
Authors:
- Sunil S. RaikarSRSunil S. Raikar
- James FelkerJFJames Felker
- Kavita N. PatelKPKavita N. Patel
- Glen LewGLGlen Lew
- Robert F. SidonioRSRobert F. Sidonio
- 1 October 2018
- journal article
- review article
- Published by Wolters Kluwer Health in Journal of Pediatric Hematology/Oncology
- Vol. 40 (7) , e470-e472
Abstract
Coagulopathy in pediatric leukemia patients is typically associated with acute promyelocytic leukemia or after asparaginase use in acute lymphoblastic leukemia. Rarely seen in acute lymphoblastic leukemia, we report 2 patients who presented with normal coagulation markers, but subsequently developed severe hypofibrinogenemia and bleeding in induction before administration of asparaginase. In both cases, cryoprecipitate was administered as initial treatment for bleeding associated with the hypofibrinogenemia. One patient was refractory to cryoprecipitate replacement and required treatment with human fibrinogen concentrate due to the persistence of hypofibrinogenemia with significant bleeding. The hypofibrinogenemia was transient in both cases and resolved within a few weeks.Keywords
This publication has 19 references indexed in Scilit:
- Whatʼs new in the pathogenesis of the coagulopathy in acute promyelocytic leukemia?Current Opinion in Hematology, 2016
- Safety of fibrinogen concentrate: analysis of more than 27 years of pharmacovigilance dataThrombosis and Haemostasis, 2015
- Fibrinogen as a therapeutic target for bleeding: a review of critical levels and replacement therapyTransfusion, 2013
- Early death rate in acute promyelocytic leukemia remains high despite all-trans retinoic acidBlood, 2011
- Disseminated intravascular coagulation complicating acute lymphoblastic leukemia: A study of childhood and adult casesLeukemia & Lymphoma, 2005
- A prospective cohort study determining the prevalence of thrombotic events in children with acute lymphoblastic leukemia and a central venous line who are treated with L‐asparaginaseCancer, 2003
- Disseminated intravascular coagulation in acute lymphoblastic leukemia at presentation and in early phase of remission induction therapyAnnals of Hematology, 1998
- Coagulation Inhibition in Manic Depression: Relevance of Prostaglandins / Acute Lymphocytic Leukaemia Complicated by Hypofibrinogenaemia without Evidence for Impaired Fibrinogen Synthesis or Disseminated Intravascular CoagulationActa Haematologica, 1983
- The effect of L‐asparaginase on plasma coagulation factors in acute lymphoblastic leukemiaCancer, 1977
- Hypofibrinogenemia associated with vincristine and prednisone therapy in lymphoblastic leukemiaCancer, 1975